Form 4: Inovio Pharmaceuticals, Inc. (INO), Kies Peter, transaction 12/15/2020

Summary

Peter Kies, CFO of INOVIO PHARMACEUTICALS, INC. [ INO ], reports exercising two Common Stock Options on 12/15/2020: 8,750 shares at $ 2.4 and 11,250 shares at $ 2.16. The same day 20,000 shares were sold at a weighted average price of $ 10.6853 under a Rule 10b5-1 trading plan, in trades from $10.52 to $10.83. After the sale 119,290 shares are owned directly, 4,500 are listed as owned by spouse, and 33,750 options remain in the $ 2.16 series. Option figures reflect the 1-for-4 reverse stock split of June 5, 2014; the signature reads Peter Kies, 12/17/2020.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * KIES PETER (Last) (First) (Middle) C/O INOVIO PHARMACEUTICALS, INC. 6769 MESA RIDGE ROAD (Street) SAN DIEGO CA 92121 (City) (State) (Zip) | KIES PETER | (Last) | (First) | (Middle) | C/O INOVIO PHARMACEUTICALS, INC. | 6769 MESA RIDGE ROAD | SAN DIEGO | CA | 92121 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol INOVIO PHARMACEUTICALS, INC. [ INO ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) CFO | Director | 10% Owner | X | Officer (give title below) | Other (specify below) | CFO
3. Date of Earliest Transaction
 (Month/Day/Year) 12/15/2020
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 12/15/2020 | M | 8,750 | A | $ 2.4 | 128,040 | D
Common Stock | 12/15/2020 | M | 11,250 | A | $ 2.16 | 139,290 | D
Common Stock | 12/15/2020 | S (1) | 20,000 | D | $ 10.6853 (2) | 119,290 | D
Common Stock | 4,500 | I | By Spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Common Stock Option | $ 2.4 (3) | 12/15/2020 | M | 8,750 (3) | 02/23/2012 | 02/23/2022 | Common Stock | 8,750 (3) | $ 0 | 0 | D
Common Stock Option | $ 2.16 (3) | 12/15/2020 | M | 11,250 (3) | 03/14/2013 | 03/14/2023 | Common Stock | 11,250 (3) | $ 0 | 33,750 | D
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
2. These transactions were executed in multiple trades at prices ranging from $10.52 to $10.83, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
3. Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014.
Remarks:
Peter Kies | 12/17/2020
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File

SEC_INO_4_filed2020-12-17_0001055726-20-000056.xml

Size

19,513 bytes

SHA-256

cc8faa047a586bd0fe1bb1d79e628c39c370779aa38372eea5eece368a895b5c

Our copy

SEC_INO_4_filed2020-12-17_0001055726-20-000056.xml

Original

www.sec.gov